Pyrimidoacridine derivatives as potential antitumor agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Development of novel antitumor agents is crucial for cancer therapy.
• Acridine derivatives have shown promise as cytotoxic agents.

Purpose of the Study:

• To synthesize novel N-alkylaminoalkyl derivatives of pyrimido[5,6,1-d,e]acridine-1,3,7-trione.
• To evaluate the in vitro and in vivo antitumor activity of these synthesized compounds.

Main Methods:

• Synthesis of pyrimidoacridine derivatives from 9,10-dihydro-9-oxo-4-acridinecarboxamides using phosgene.
• In vitro cytotoxicity testing against L 1210 leukemia.
• In vivo antitumor activity testing against P388 leukemia.

Main Results:

• Several N-alkylaminoalkyl derivatives of pyrimido[5,6,1-d,e]acridine-1,3,7-trione were successfully synthesized.
• One synthesized compound demonstrated in vivo antitumor activity against P388 leukemia.
• Another compound exhibited significant in vitro cytotoxic activity against L 1210 leukemia but was inactive or toxic in vivo.

Conclusions:

• The synthesized pyrimidoacridine derivatives represent a new class of potential anticancer drugs.
• Structure-activity relationships warrant further investigation to optimize efficacy and reduce toxicity.